Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 17;23(1):475.
doi: 10.1186/s12879-023-08449-9.

High incidence of fosfomycin-resistant uropathogenic E. coli among children

Affiliations

High incidence of fosfomycin-resistant uropathogenic E. coli among children

Wedad M Abdelraheem et al. BMC Infect Dis. .

Abstract

Background: There are few epidemiological or molecular data on Escherichia coli (E. coli) strains resistant to fosfomycin. In this study, we described the occurrence and characterization of fosfomycin-resistant uropathogenic E. coli (UPEC) isolated from children.

Materials and methods: This study was carried out on 96 E. coli isolates obtained from children with urinary tract infections. Two methods were performed to detect fosfomycin resistance: The agar dilution method and the rapid fosfomycin test. The disc diffusion method was done to detect the antimicrobial susceptibility pattern of all isolates. The phylogenetic grouping of all isolates was done according to the modified Clermont method. Conventional PCR was performed to detect plasmid-mediated fosfomycin-resistant genes (fos genes) and the blaCTX-M gene.

Results: Analyses of data were performed by SPSS software. A high percentage of fosfomycin resistance (37/96; 38.5%) was reported among UPEC isolates. The fosfomycin-resistant strains showed a higher resistance rate than fosfomycin-susceptible isolates to different antibiotics. E group (62.2%) was the most predominant phylogenetic group among the fosfomycin-resistant UPEC isolates, followed by Group B2 (21.6%) and group D (13.5%). The fos genes were detected in 21 isolates with the fosA3 gene as the most frequent, which was detected in 11 isolates followed by fosA (8), fosC2 (4), fosA4(1), and fosA5(1) genes.

Conclusion: This is the first report of a high prevalence of plasmid-mediated fosfomycin-resistant UPEC in Egypt. All of these isolates were multidrug-resistant to the tested antibiotics. Close monitoring of such strains is mandatory to prevent widespread dissemination of the genes code for antibiotic resistance.

Keywords: Escherichia coli; Fosfomycin resistance; Phylogenetic analysis; Urinary tract infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Fosfomycin MIC of the phosphonoformate test positive and negative isolates: PPF, phosphonoformate test

References

    1. Shaikh N, Mattoo TK, Keren R, Ivanova A, Cui G, Moxey-Mims M, Majd M, Ziessman HA, Hoberman A. Early antibiotic treatment for Pediatric Febrile urinary tract infection and renal scarring. JAMA Pediatr. 2016;170(9):848–54. doi: 10.1001/jamapediatrics.2016.1181. - DOI - PubMed
    1. Navidinia M, Peerayeh SN, Fallah F, Bakhshi B, Sajadinia RS. Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection. Braz J Microbiol. 2014;45(2):509–14. doi: 10.1590/S1517-83822014000200019. - DOI - PMC - PubMed
    1. Maczynska B, Frej-Madrzak M, Sarowska J, Woronowicz K, Choroszy-Krol I, Jama-Kmiecik A. Evolution of Antibiotic Resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates in a Multi-Profile Hospital over 5 years (2017–2021). J Clin Med 2023, 12(6). - PMC - PubMed
    1. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious Diseases Society of America and the european Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–120. doi: 10.1093/cid/ciq257. - DOI - PubMed
    1. Baquero-Artigao F, Del Rosal Rabes T. Fosfomycin in the pediatric setting: evidence and potential indications. Rev Esp Quimioter. 2019;32(Suppl 1):55–61. - PMC - PubMed